Lobby organisation
Astellas Pharma Europe Limited
Business / industry · Health & pharma · HQ: United Kingdom · Transparency Register entry
As of 9 September 2026, Astellas Pharma Europe Limited appears in 9 declared MEP meetings (4 different MEPs), most often with European People's Party.
In their own words
“At Astellas, we are relentless in our pursuit of scientific progress and in identifying unmet medical needs by monitoring the changes in healthcare from multiple perspectives. We are committed to the realization of greater value by patients and healthcare systems around the world. We achieve this by leveraging our strengths to create innovative new drugs and to find solutions that…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 9 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2025. Bar length is relative to its busiest year (6 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 9 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 25 Mar 2025 | Pascal Arimont | Addressing the Needs of Individuals with Geographic Atrophy (GA) and Vision Impairment – Breakfast discussion |
| 25 Feb 2025 | Pascal Arimont | Geographic Atrophy |
| 16 Jan 2025 | Pascal Arimont | Geographic Atrophy |
| 11 Dec 2024 | Pascal Arimont | Geographic Atrophy |
| 4 Dec 2024 | Elena Nevado del Campo | Plan de Acción Europeo en Trasplantes |
| 4 Nov 2024 | Pascal Arimont | Geographic Atrophy and EU Activity |
| 14 Oct 2024 | Vytenis Povilas Andriukaitis | EU health policy |
| 9 Sep 2024 | Pascal Arimont | Growing burden of geographic |
| 23 Jan 2024 | Laura Ballarín Cereza | Pharmaceutical Package (Regulation) |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.